Venus Remedies stock rises 6%, bags tender for antibiotic product from UNICEF
Shares of Venus Remedies surged about 6 per cent on the NSE following the receipt of tender from UNICEF for
Continue readingThe Number One Finance & Business Blog!
Shares of Venus Remedies surged about 6 per cent on the NSE following the receipt of tender from UNICEF for
Continue readingVenus Remedies has received marketing authorisation for its oncology drugs in Ukraine. This includes Paclitaxel, 100mg/16.7mL, 260mg/43.3mL, 300mg/50mL and 30mg/5mL,
Continue readingVenus Remedies has announced that its consumer healthcare division, R3SET, forays into the wellness segment, coupled with the expansion of
Continue reading